Tarsus Pharmaceuticals Inc (TARS)

Total Costs & Expenses

$193.82M

Quarterly · Period ending: · USD

TARS logo

TARS Total Costs & Expenses

Latest reported$193.82M
TARS Quarterly Total Costs & Expenses ($337.50K → $193.82M)
High-resolution chart · PNG

TARS total costs & expenses history

Quarterly · USD. Dates are reporting period ends; fiscal years can differ from calendar years.

Tarsus Pharmaceuticals Inc Total Costs & Expenses — Quarterly (USD)
Period endingTotal Costs & Expenses (USD)
193,820,000
168,176,000
159,644,000
133,226,000
124,844,000
104,615,000
90,829,000
73,280,000
74,115,000
65,298,000
57,526,000
42,806,000
32,821,000
27,452,000
25,061,000
22,906,000
20,501,000
20,060,000
14,786,000
16,945,000
14,735,000
22,718,000
11,477,000
10,141,000
3,263,000
2,118,000
1,084,000
633,000
337,500
337,500
Data is provided for informational purposes only and does not constitute investment advice. Past performance is not indicative of future results.